Syngene International Ltd Q2 2022 Earnings Call Transcript - Thomson StreetEvents

Syngene International Ltd Q2 2022 Earnings Call Transcript

Syngene International Ltd Q2 2022 Earnings Call Transcript - Thomson StreetEvents
Syngene International Ltd Q2 2022 Earnings Call Transcript
Published Oct 21, 2021
Published Oct 21, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of SYNN.NS earnings conference call or presentation 21-Oct-21 9:00am GMT

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Syngene International Ltd
Ticker
SYNN.NS
Time
9:00am GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Alankar Garude - Macquarie Research - Analyst : Sir, my first question is on the guidance. We have reported 28% growth in the first half. Even if I assume, say, a 15% growth for FY '22, it just implies a 5% growth in the second half despite the good demand environment, as you mentioned. So the question is what is the upside risk to this FY '22 top line guidance of mid-teens?

Question: Alankar Garude - Macquarie Research - Analyst : Understood. Okay.

Question: Alankar Garude - Macquarie Research - Analyst : No. I understood that. Thanks for the context. My second question is you have mentioned about excellent demand in emerging biopharma Discovery Services. Can you also comment on the demand for Biologics Manufacturing? Also, if you could highlight where are we in the evolution curve with respect to the return on investments for Biologics Manufacturing?

Question: Charulata Gaidhani - Dalal & Broacha Stock Broking Pvt Ltd., Research Division - Analyst : Congrats on the good numbers. And I wanted to know how much would be remdesivir in the current quarter?

Question: Charulata Gaidhani - Dalal & Broacha Stock Broking Pvt Ltd., Research Division - Analyst : And the second question pertains to the FDA approval for the Mangalore plant. Then, you said 24 months. Would it mean end of -- middle of FY '24?

Question: Charulata Gaidhani - Dalal & Broacha Stock Broking Pvt Ltd., Research Division - Analyst : Okay. Okay. Right. And in terms of the approvals?

Question: Charulata Gaidhani - Dalal & Broacha Stock Broking Pvt Ltd., Research Division - Analyst : Right. And do you expect the approval for the Biologics plant? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. OCTOBER 21, 2021 / 9:00AM, SYNN.NS - Q2 2022 Syngene International Ltd Earnings Call

Table Of Contents

Syngene International Ltd Q3 2023 Earnings Call Transcript – 2023-01-24 – US$ 54.00 – Edited Transcript of SYNN.NS earnings conference call or presentation 24-Jan-23 9:30am GMT

Syngene International Ltd Q2 2023 Earnings Call Transcript – 2022-10-20 – US$ 54.00 – Edited Transcript of SYNN.NS earnings conference call or presentation 20-Oct-22 6:30am GMT

Syngene International Ltd Q1 2023 Earnings Call Transcript – 2022-07-21 – US$ 54.00 – Edited Transcript of SYNN.NS earnings conference call or presentation 21-Jul-22 9:30am GMT

Syngene International Ltd Q4 2022 Earnings Call Transcript – 2022-04-28 – US$ 54.00 – Edited Transcript of SYNN.NS earnings conference call or presentation 28-Apr-22 9:30am GMT

Syngene International Ltd Q3 2022 Earnings Call Transcript – 2022-01-20 – US$ 54.00 – Edited Transcript of SYNN.NS earnings conference call or presentation 20-Jan-22 10:30am GMT

Syngene International Ltd Q1 2022 Earnings Call Transcript – 2021-07-21 – US$ 54.00 – Edited Transcript of SYNN.NS earnings conference call or presentation 21-Jul-21 8:30am GMT

Syngene International Ltd Q4 2021 Earnings Call Transcript – 2021-04-28 – US$ 54.00 – Edited Transcript of SYNN.NS earnings conference call or presentation 28-Apr-21 9:30am GMT

Syngene International Ltd Q3 2021 Earnings Call Transcript – 2021-01-21 – US$ 54.00 – Edited Transcript of SYNN.NS earnings conference call or presentation 21-Jan-21 9:30am GMT

Syngene International Ltd Q2 2021 Earnings Call Transcript – 2020-10-22 – US$ 54.00 – Edited Transcript of SYNN.NS earnings conference call or presentation 22-Oct-20 7:45am GMT

Syngene International Ltd Q1 2021 Earnings Call Transcript – 2020-07-22 – US$ 54.00 – Edited Transcript of SYNN.NS earnings conference call or presentation 22-Jul-20 9:00am GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Syngene International Ltd Q2 2022 Earnings Call Transcript" Oct 21, 2021. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2022-Syngene-International-Ltd-Earnings-Call-T15000006>
  
APA:
Thomson StreetEvents. (2021). Syngene International Ltd Q2 2022 Earnings Call Transcript Oct 21, 2021. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2022-Syngene-International-Ltd-Earnings-Call-T15000006>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.